Grandeur Peak Global Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,365
Closed -$436K 124
2022
Q2
$436K Sell
30,365
-531,170
-95% -$9.22M 0.03% 103
2022
Q1
$12.7M Sell
561,535
-3,047
-0.5% -$59.1K 0.6% 37
2021
Q4
$10.6M Buy
564,582
+150,103
+36% +$4.01M 0.48% 39
2021
Q3
$13.6M Buy
414,479
+89,169
+27% +$3.33M 0.64% 29
2021
Q2
$13.9M Buy
325,310
+73,227
+29% +$2.86M 0.66% 31
2021
Q1
$9.66M Buy
252,083
+9,100
+4% +$387K 0.53% 37
2020
Q4
$10.6M Buy
242,983
+41,362
+21% +$1.56M 0.61% 36
2020
Q3
$7.93M Buy
+201,621
New +$6.51M 0.54% 42
2015
Q4
Sell
-79,156
Closed -$1.25M 123
2015
Q3
$1.25M Buy
+79,156
New +$2M 0.28% 78

Other funds holding CSII

Grandeur Peak Global Advisors's CSII Position: Q3 2022 in Review

Grandeur Peak Global Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2022, closing a stake of 30,365 shares — an estimated $436K sold.

Grandeur Peak Global Advisors first reported a position in CSII in Q3 2015 and held it in 9 quarters. The position peaked at $13.9M in Q2 2021. 163 funds tracked by Wall St. Rank hold CSII as of Q3 2022.

  • Grandeur Peak Global Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q3 2022 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 30,365 Cardiovascular Systems, Inc. shares in Q3 2022, an estimated $436K.
  • Grandeur Peak Global Advisors first reported a position in Cardiovascular Systems, Inc. in Q3 2015 and held it in 9 quarters.
  • Grandeur Peak Global Advisors's Cardiovascular Systems, Inc. position peaked at $13.9M in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2022.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2022, filed 17 Nov 2022.